Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04065711 · ClinicalTrials.gov registry record · NA
Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite
A NA study, sponsored by Soliton.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT04065711: Completed NA study, sponsored by Soliton.
NCT04065711 is a NA study that has completed, run by Soliton. The registered enrollment target is 67 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04065711, a NA study, has completed, sponsored by Soliton.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
To evaluate the safety, and efficacy of Soliton's Rapid Acoustic Pulse (RAP) device for the temporary improvement in the appearance of cellulite.
Primary Outcome
The primary objective is to demonstrate freedom from unexpected adverse events (UAEs) and serious adverse events (SAEs) directly attributable to the RAP device or treatment.
Interventions
- DEVICE Soliton's Rapid Acoustic Pulse (RAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2019-07-20 |
| Est. Completion | 2021-08-26 |
| Phase | NA |
What the finished NCT04065711 record still lists
NCT04065711 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Soliton's Rapid Acoustic Pulse (RAP) is the first listed.
NCT04065711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04065711 about?
NCT04065711 is a clinical study titled "Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite". To evaluate the safety, and efficacy of Soliton's Rapid Acoustic Pulse (RAP) device for the temporary improvement in the appearance of cellulite.
What is the current status of trial NCT04065711?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2019-07-20. Estimated completion is 2021-08-26.
What interventions are being tested in trial NCT04065711?
The interventions under investigation include: Soliton's Rapid Acoustic Pulse (RAP) (DEVICE).
Who is sponsoring clinical trial NCT04065711?
This trial is sponsored by Soliton, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04065711's enrollment target sits among peer trials
67 1139th of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI